Showing results (41-50 of 74) with videos related to
Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|December 2, 2009
CD4(+) CD25(+) Foxp3(+) T regulatory cells with limited TCR diversity in control of autoimmunityDennis Adeegbe, Takaji Matsutani, Jing Yang, et al.Journal for Immunotherapy of Cancer|September 3, 2021
High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4+ and CD8+ neoantigen-specific T cells to promote antitumor immunityRosmely Hernandez, Kathryn M LaPorte, Sunnie Hsiung, et al.Diabetes|March 20, 2023
Immunotherapy With Low-Dose IL-2/CD25 Prevents β-Cell Dysfunction and Dysglycemia in Prediabetic NOD MiceFarhan M Qureshi, Julia K Panzer, Janika Põder, et al.Journal of Clinical Immunology|August 30, 2008
IL-2 family of cytokines in T regulatory cell development and homeostasisThomas R Malek, Aixin Yu, Linjian Zhu, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 25, 2016
Developmental Progression and Interrelationship of Central and Effector Regulatory T Cell SubsetsKevin H Toomer, Xiaomei Yuan, Jing Yang, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 13, 2012
IL-2 receptor signaling is essential for the development of Klrg1+ terminally differentiated T regulatory cellsGuoyan Cheng, Xiaomei Yuan, Matthew S Tsai, et al.Diabetes|January 11, 2015
Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetesAixin Yu, Isaac Snowhite, Francesco Vendrame, et al.Blood|April 2, 2014
Heat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in miceRobert G Newman, Michael J Dee, Thomas R Malek, et al.Cancer Immunology, Immunotherapy : CII|October 10, 2020
Sustained IL-2R signaling of limited duration by high-dose mIL-2/mCD25 fusion protein amplifies tumor-reactive CD8+ T cells to enhance antitumor immunityRosmely Hernandez, Kevin H Toomer, Janika Põder, et al.Nature Reviews. Drug Discovery|October 13, 2018
Regulatory T cells in the treatment of diseaseAmir Sharabi, Maria G Tsokos, Ying Ding, et al.Pageof 8